| Structure | Chemical Name | CAS | MF |
|
Mc-Val-Cit-PAB-Cl
|
1639351-92-0
|
C28H39ClN6O6
|
|
5H-Benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide, 2-[(3aR,6aS)-hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl]-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-, rel-
|
1639357-93-9
|
C28H27N7O2S
|
|
3,6-dichloro-2,4-dimethylpyridine
|
1639373-35-5
|
C7H7Cl2N
|
|
N,N''-Bis(2-aminoethyl)thiourea Dihydrochloride
|
1639405-29-0
|
C5H15ClN4S
|
|
TCNH10
|
1639407-43-4
|
C49H30O
|
|
Bis [2- (2,4-difluorophenyl) -5-trifluoromethylpyridine] [1,10-phenanthroline] iridium hexafluorophosphate
|
1639408-64-2
|
C36H18F16IrN4P
|
|
9-Azido-Neu5DAz
|
1639411-87-2
|
C14H22N6O8
|
|
Tenalisib
|
1639417-53-0
|
C23H18FN5O2
|
|
Tenalisib R Enantiomer
|
1639417-54-1
|
C23H18FN5O2
|
|
JH-VIII-157-02
|
1639422-97-1
|
C28H27N5O2
|
|
1,3,5-Triazine, 2,4-diphenyl-6-(9,9'-spirobi[9H-fluoren]-3-yl)-
|
1639424-37-5
|
C40H25N3
|
|
MATFPFPXUXCLHI-UHFFFAOYSA-N
|
1639429-81-4
|
C20H18N2O
|
|
4-bromo-3-methyl-1H-pyrrolo[2,3-c]pyridine
|
1639444-93-1
|
C8H7BrN2
|
|
(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide
|
1639447-03-2
|
C68H45O4P
|
|
DTBT-2Th48Br
|
1639449-99-2
|
C58H86Br2N2S5
|
|
(1S,2S)-2-{[(tert-butoxy)carbonyl]amino}-1-fluorocyclobutane-1-carboxylic acid
|
1639454-85-5
|
C10H16FNO4
|
|
5-Methoxy-1-Methyl-1H-pyrrolo[3,2-b]pyridine
|
1639457-19-4
|
C9H10N2O
|
|
Diflunisal Impurity 3
|
1639462-15-9
|
C13H8F2O3
|
|
(4S,4'S)-2,2'-Cyclopentylidenebis[4,5-dihydro-4-phenylox
azole]
|
1639791-77-7
|
C23H24N2O2
|
|
Saroglitazar (Magnesium)
|
1639792-20-3
|
C50H56MgN2O8S2
|
|
19-(2-iodoethyl)heptatriacontane
|
1639798-42-7
|
C39H79I
|
|
19-(4-iodobutyl)heptatriacontane
|
1639798-43-8
|
C41H83I
|
|
Maresin 2
|
1639809-46-3
|
C22H32O4
|
|
Longiferone B
|
1639810-67-5
|
C15H22O
|
|
2-(3-Bromophenyl)-5-phenylpyridine
|
1639810-83-5
|
C17H12BrN
|
|
1639833-41-2
|
1639833-41-2
|
C7H6N4O
|
|
Deuterated Crosslinker DSP-d8
|
1639836-65-9
|
C14H8D8N2O8S2
|
|
7-phenyl-6,8-dioxaspiro[3.5]nonane-2-carboxylic acid
|
1639838-84-8
|
C14H16O4
|
|
DI-FMOC-SELENO-L-CYSTINE
|
1639843-33-6
|
C36H32N2O8Se2
|
|
Fmoc-Sec(Trt)-OH
|
1639843-37-0
|
C37H31NO4Se
|
|
(2E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
|
1639856-62-4
|
C18H18O4
|
|
3-Amino-5-ethynylbenzoic acid
|
1639866-72-0
|
C9H7NO2
|
|
4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)butan-1-aminium trifluoroacetate
|
1639876-58-6
|
C10H13F3N2O4
|
|
tert-Butyl (6R)-6-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-5-carboxylate
|
1639881-13-2
|
C12H19N3O2
|
|
(2R,5R)-2,5-DiMethylMorpholine hydrochloride
|
1639886-52-4
|
C6H14ClNO
|
|
tBID
|
1639895-85-4
|
C11H3Br4N3O2
|
|
(2S,5R)-2,5-diMethylMorpholine
|
1639924-58-5
|
C6H13NO
|
|
LolCDE-IN-1
|
1639933-78-0
|
C21H16FN3O
|
|
Mc-Val-Ala-PAB-PNP
|
1639939-40-4
|
C32H37N5O10
|
|
Ethyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetate
|
1639958-04-5
|
C15H22BNO4
|
|
di-tert-butyl 2,5,8-triazaspiro[3.5]nonane-2,8-dicarboxylate
|
1639963-79-3
|
C16H29N3O4
|
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid
|
1639970-62-9
|
C22H23NO4
|
|
Pyridine, 2-bromo-6-fluoro-3-nitro-
|
1639977-00-6
|
C5H2BrFN2O2
|
|
1H-Pyrrolo[2,3-c]pyridine, 7-bromo-5-fluoro-
|
1639977-12-0
|
C7H4BrFN2
|
|
4-(1,3,2-Dioxaborinan-2-yl)phenol
|
1640035-73-9
|
C9H11BO3
|
|
(2-Phenylpropan-2-yloxy)(trifluoromethyl)sulfane, 98%
|
1640084-14-5
|
C10H11F3OS
|
|
Capstone FS-30
|
1640092-35-8
|
|
|
Ethyl 3-fluoro-4-formylbenzoate
|
1640117-38-9
|
C10H9FO3
|
|
6-bromo-[1,2,4]triazolo[1,5-b]pyridazin-2-amine
|
1640120-88-2
|
C5H4BrN5
|
|
6-Bromo-1,7-dimethyl-1H-oxazolo[5,4-b]pyridin-2-one
|
1640124-55-5
|
C8H7BrN2O2
|
|
6-Bromo-7-methyl-1H-oxazolo[5,4-b]pyridin-2-one
|
1640124-56-6
|
C7H5BrN2O2
|
|
Th48-Sn
|
1640126-30-2
|
C28H54SSn
|
|
YIL 781 hydrochloride
|
1640226-17-0
|
C24H29ClFN3O2
|
|
PCN-223(H)
|
1640226-29-4
|
C144H78N12O32Zr6
|
|
GS-9901
|
1640247-87-5
|
C22H17ClFN9O
|
|
TH588 (hydrochloride)
|
1640282-30-9
|
C13H13Cl3N4
|
|
I-CBP112
|
1640282-31-0
|
C27H36N2O5
|
|
[1(2H),4'-Bipyridin]-2-one, 3-chloro-4-[(3,5-difluoro-2-pyridinyl)methoxy]-2'-[2-(1-hydroxy-1-methylethyl)-4-pyrimidinyl]-5',6-dimethyl-, (2'S)-
|
1640282-42-3
|
C25H22ClF2N5O3
|
|
1,3-Dibromo-5-(2-decyltetradecyl)-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione
|
1640286-62-9
|
C30H49Br2NO2S
|
|
Oclacitinib maleate
|
1640292-55-2
|
C19H27N5O6S
|
|
ASP4132
|
1640294-30-9
|
C39H43F3N6O5S
|
|
CH3CH2NH3PbI3(EAPbI3)
|
1640335-04-1
|
C2H11I3NPb
|
|
METHYL 4,5-DIFLUORO-2-IODOBENZOATE
|
1640342-92-2
|
C8H5F2IO2
|
|
2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoic acid
|
1640351-46-7
|
C15H22N2O5
|
|
(2S)-2-AMINO-2-(6-METHOXY(3-PYRIDYL))ETHAN-1-OL DIHYDROCHLORIDE
|
1640848-68-5
|
C8H13ClN2O2
|
|
(2R)-2-AMINO-2-(6-METHOXY(3-PYRIDYL))ETHAN-1-OL DIHYDROCHLORIDE
|
1640848-71-0
|
C8H13ClN2O2
|
|
(S)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride
|
1640848-91-4
|
C8H14Cl2N2O2
|
|
(R)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride
|
1640848-93-6
|
C8H14Cl2N2O2
|
|
17878-A2
|
1640894-12-7
|
C26H22N2O5
|
|
17878-A3
|
1640894-15-0
|
C26H24N2O5
|
|
Procaterol Impurity 7
|
1640918-78-0
|
C16H22N2O3
|
|
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid
|
1640968-91-7
|
C28H35NO4
|
|
Tofacitinib Impurity 77
|
1640971-51-2
|
C16H20N6O2
|
|
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
|
1640971-60-3
|
C14H20N6O
|
|
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride
|
1640971-87-4
|
C10H18ClN3O
|
|
Tofacitinib Impurity 6
|
1640972-35-5
|
C16H22N6O
|
|
1H,3H-Furo[3,4-c]isoxazole, 6a-(5-bromo-2-fluorophenyl)tetrahydro-1-[(1R)-1-phenylpropyl]-, (3aS,6aS)-
|
1640975-25-2
|
C20H21BrFNO2
|
|
2,6-bis[4-(diphenylamino)phenyl]- 9,10-Anthracenedione
|
1640978-33-1
|
C50H34N2O2
|
|
Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)-
|
1640981-02-7
|
C18H20N2O4
|
|
1H-Benzimidazole-6-carboxylic acid, 4-hydroxy-2-methyl-1-(phenylmethyl)-, ethyl ester
|
1640981-16-3
|
C18H18N2O3
|
|
1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid
|
1640981-19-6
|
C16H14N2O3
|
|
1H-Benzimidazole-6-carboxamide, 4-hydroxy-N,N,2-trimethyl-1-(phenylmethyl)-
|
1640981-20-9
|
C18H19N3O2
|
|
2-(4-Bromo-2-formylphenoxy)acetic acid
|
1640995-60-3
|
C11H15ClN2O2
|
|
2-Ethoxy-5-(ethoxyMethyl)thiazole
|
1640995-61-4
|
C8H13NO2S
|
|
(2-Aminothiazol-5-yl)methanol hydrochloride
|
1640995-62-5
|
C4H7ClN2OS
|
|
(4-Chloropyridin-2-yl)methanamine hydrochloride
|
1640995-63-6
|
C6H8Cl2N2
|
|
tert-butyl4-((2S,5S)-1-((4-nitrophenyl)sulfonyl)-5-(((4-nitrophenyl)sulfonyl)oxy)piperidine-2-carboxamido)piperidine-1-carboxylate
|
1640998-70-4
|
C28H35N5O12S2
|
|
(3-ethyl-4-hydroxyphenyl)boronic acid
|
1641540-51-3
|
C8H11BO3
|
|
1-Cyclopropyl-7,8-difluoro-1,4-dihydro-6-methoxy-4-oxo-3-quinolinecarboxylic acid
|
1641561-55-8
|
C14H11F2NO4
|
|
2-(5-methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1641570-76-4
|
C14H21BO3
|
|
1,3,2-Dioxaborolane, 2-[3-(difluoromethoxy)-5-fluorophenyl]-4,4,5,5-tetramethyl-
|
1641578-50-8
|
C13H16BF3O3
|
|
(E)-ethyl 3-(2-aMino-5-(benzylthio)phenyl)acrylate
|
1641578-95-1
|
C18H19NO2S
|
|
1-Chloro-5-iodo-4-methoxy-2-trifluoromethyl-benzene
|
1641579-84-1
|
C8H5ClF3IO
|
|
2-(3-(Difluoromethoxy)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1641580-18-8
|
C13H16BF3O3
|
|
Methyl 4-cyano-2-(trifluoromethyl)benzoate
|
1641588-74-0
|
C10H6F3NO2
|
|
Alfacalcidol-D6
|
1641940-94-4
|
C27H44O2
|
|
3-O-β-D-Glucopyranosyl Alternariol
|
1642128-76-4
|
C20H20O10
|
|
Cobalt(2+), tris(acetonitrile)[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl]-, (OC-6-11)-hexafluoroantimonate(1-) (1:2)
|
1642132-26-0
|
C16H24CoF6N3Sb+
|
|
4a€-O-Desmethyl-3-O-acetylpapaveroxine
|
1642137-73-2
|
C23H25NO8
|
|
13-O-Acetyl Papaveroxine
|
1642137-74-3
|
C24H27NO8
|